These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16682089)

  • 1. The applicability of the Asian modified criteria of the metabolic syndrome in the Korean population.
    Moon JY; Park S; Rhee JH; Jee SH; Park CM; Choi DS; Park HY; Ko YG; Choi D; Jang Y; Chung N
    Int J Cardiol; 2007 Jan; 114(1):83-9. PubMed ID: 16682089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.
    Hunt KJ; Resendez RG; Williams K; Haffner SM; Stern MP;
    Circulation; 2004 Sep; 110(10):1251-7. PubMed ID: 15326061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
    Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
    Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions.
    Nilsson PM; Engström G; Hedblad B
    Diabet Med; 2007 May; 24(5):464-72. PubMed ID: 17381496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
    Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
    Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population: the suita study.
    Kokubo Y; Okamura T; Yoshimasa Y; Miyamoto Y; Kawanishi K; Kotani Y; Okayama A; Tomoike H
    Hypertens Res; 2008 Nov; 31(11):2027-35. PubMed ID: 19098374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria.
    Li WJ; Xue H; Sun K; Song XD; Wang YB; Zhen YS; Han YF; Hui RT
    Chin Med J (Engl); 2008 Aug; 121(16):1532-6. PubMed ID: 18985935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
    Cussons AJ; Watts GF; Burke V; Shaw JE; Zimmet PZ; Stuckey BG
    Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.
    Choi KM; Kim SM; Kim YE; Choi DS; Baik SH; Lee J;
    Metabolism; 2007 Apr; 56(4):552-8. PubMed ID: 17379016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low serum adiponectin is independently associated with both the metabolic syndrome and angiographically determined coronary atherosclerosis.
    Saely CH; Risch L; Hoefle G; Rein P; Muendlein A; Marte T; Aczel S; Langer P; Drexel H
    Clin Chim Acta; 2007 Aug; 383(1-2):97-102. PubMed ID: 17550784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of the components of metabolic syndrome on heart rate variability: using the NCEP-ATP III and IDF definitions.
    Min KB; Min JY; Paek D; Cho SI
    Pacing Clin Electrophysiol; 2008 May; 31(5):584-91. PubMed ID: 18439173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Waist circumference alone predicts insulin resistance as good as the metabolic syndrome in elderly women.
    Nilsson G; Hedberg P; Jonason T; Lönnberg I; Tenerz A; Forberg R; Ohrvik J
    Eur J Intern Med; 2008 Nov; 19(7):520-6. PubMed ID: 19013381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: the Korea NHANES study.
    Yoon YS; Lee ES; Park C; Lee S; Oh SW
    Int J Obes (Lond); 2007 Mar; 31(3):528-34. PubMed ID: 16865099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts?
    Iribarren C; Go AS; Husson G; Sidney S; Fair JM; Quertermous T; Hlatky MA; Fortmann SP
    J Am Coll Cardiol; 2006 Nov; 48(9):1800-7. PubMed ID: 17084253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between arterial stiffness and the risk of coronary artery disease in subjects with and without metabolic syndrome.
    Koji Y; Tomiyama H; Yamada J; Yambe M; Motobe K; Shiina K; Yamashina A
    Hypertens Res; 2007 Mar; 30(3):243-7. PubMed ID: 17510506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome and prediabetes identify overlapping but not identical populations.
    Diamantopoulos EJ; Andreadis EA; Tsourous GI; Ifanti GK; Katsanou PM; Georgiopoulos DX; Vassilopoulos CV; Dimitriadis G; Raptis SA
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):377-83. PubMed ID: 16915541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome in type 2 diabetes: When does it matter?
    Wong J; Molyneaux L; Constantino MI; Twigg SM; Yue DK
    Diabetes Obes Metab; 2006 Nov; 8(6):690-7. PubMed ID: 17026494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.